Selective insulin resistance influences pathogenesis and treatment of type 2 diabetes and metabolic syndrome. Downregulation of the antiatherogenic pathway and maintained activity of the proatherogenic and cancerogenic pathways lead to atherosclerosis and cancer. Exogenous insulin added to "compensatory" hyperinsulinemia might worsen the primary end points, resulting in potential increase in cardiovascular and cancer events in spite of improvement of surrogate metabolic end points. Conversely, metformin can improve primary and surrogate end points.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11892-008-0040-z | DOI Listing |
Publication Analysis
Top Keywords
effects chronic
4
chronic hyperinsulinemia
4
hyperinsulinemia insulin-resistant
4
insulin-resistant patients
4
patients selective
4
selective insulin
4
insulin resistance
4
resistance influences
4
influences pathogenesis
4
pathogenesis treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!